The FAM20A gene plays a crucial role in the development of enamel, which is the hard, protective outer layer of our teeth. Mutations in the FAM20A gene can lead to a condition known as Amelogenesis Imperfecta Type 1G (AI1G), characterized by dental enamel that is thin, improperly formed, or completely absent, leading to a range of dental problems including increased sensitivity, rapid wear, and aesthetic concerns.
To diagnose this specific type of Amelogenesis Imperfecta, genetic testing for mutations in the FAM20A gene is essential. This test involves analyzing the individual's DNA to identify any alterations in the FAM20A gene that could be responsible for the condition. It's a crucial step not only for diagnosis but also for understanding the inheritance pattern within a family, which can help in family planning and managing the condition.
DNA Labs UAE offers this specialized genetic test for identifying mutations in the FAM20A gene associated with Amelogenesis Imperfecta Type 1G. The test cost is set at 4400 AED. Conducted in a state-of-the-art facility, the test provides families and individuals with accurate and crucial information regarding the genetic basis of their dental condition, paving the way for targeted treatments and management strategies. DNA Labs UAE employs advanced genetic testing technologies to ensure reliable results, making it a trusted choice for individuals seeking clarity on their genetic predisposition to Amelogenesis Imperfecta Type 1G.
The ITGB6 gene amelogenesis imperfecta type 1H genetic test is a specialized diagnostic procedure aimed at detecting mutations in the ITGB6 gene, which are linked to amelogenesis imperfecta type 1H, a rare genetic condition. This condition affects dental enamel formation, leading to teeth that are discolored, pitted, or otherwise malformed. Early and accurate diagnosis through this genetic test can be crucial for the management and treatment of the condition, including dental care planning and genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis of the ITGB6 gene to identify specific genetic alterations. The test cost is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test, individuals suspected of having amelogenesis imperfecta type 1H or families with a history of the condition can gain valuable insights into their genetic makeup, facilitating informed decisions regarding their dental and overall health management.
The KLK4 Gene Amelogenesis Imperfecta Type 2A1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the KLK4 gene, which are associated with Amelogenesis Imperfecta (AI) Type 2A1. Amelogenesis Imperfecta is a rare genetic condition characterized by the improper development of tooth enamel, leading to teeth that are pitted, grooved, discolored, and prone to rapid wear and breakage. Type 2A1 specifically refers to a hypomaturation-hypoplastic form with taurodontism, a condition affecting the teeth's internal structure.
The test, available at DNA Labs UAE, is crucial for the accurate diagnosis of AI Type 2A1, enabling targeted treatment plans and genetic counseling for affected individuals and their families. By analyzing a patient's DNA sample, the test can detect the presence of mutations in the KLK4 gene, which plays a significant role in the maturation of tooth enamel.
Priced at 4400 AED, the KLK4 Gene Amelogenesis Imperfecta Type 2A1 Genetic Test is a valuable resource for patients exhibiting symptoms of AI, offering them a clear path towards understanding their condition and managing its effects more effectively. This test is an essential step for those seeking a definitive diagnosis and is a testament to the advancements in genetic testing and personalized medicine.
The DNAH9 gene plays a crucial role in the proper functioning of cilia, which are microscopic, hair-like structures on the surface of cells. Mutations in the DNAH9 gene can lead to a condition known as Primary Ciliary Dyskinesia (PCD), a rare genetic disorder that affects the respiratory tract, fertility, and can cause situs inversus (a condition where the major visceral organs are reversed or mirrored from their normal positions).
The DNAH9-related genetic test is a specialized diagnostic tool designed to identify mutations in the DNAH9 gene, providing crucial information for the diagnosis and management of PCD. This test is particularly important for individuals showing symptoms of PCD or those with a family history of the condition, as early diagnosis can lead to better management of the symptoms and improve quality of life.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the DNAH9 gene. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify the mutations associated with the condition. Through this testing, individuals and families can gain valuable insights into their genetic health, enabling informed decisions regarding treatment and management of Primary Ciliary Dyskinesia.
The P2RX2 gene progressive hearing loss genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the P2RX2 gene, which are linked to progressive hearing loss. This gene plays a crucial role in the function of hair cells within the inner ear, which are essential for normal hearing. Mutations in the P2RX2 gene can lead to deteriorating hearing ability over time, making early detection vital for effective management and treatment options.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies associated with hearing loss. By identifying these mutations early, individuals and their healthcare providers can explore potential interventions, including hearing aids, cochlear implants, or other supportive therapies, to improve quality of life or slow the progression of hearing loss.
Offered at DNA Labs UAE, the cost of the P2RX2 gene progressive hearing loss genetic test is 4400 AED. The test is conducted with precision and confidentiality, ensuring that individuals receive accurate results and the necessary guidance for further steps. For those with a family history of hearing loss or early signs of hearing impairment, this test provides a crucial resource for early detection and intervention, emphasizing the importance of genetic testing in managing hereditary conditions.
The "SFTPA2 Gene Pulmonary Fibrosis Idiopathic Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SFTPA2 gene, which are associated with an increased risk of developing idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease characterized by the thickening and scarring (fibrosis) of lung tissue, which can severely impact breathing and oxygen transfer. The SFTPA2 gene plays a crucial role in the immune response and the maintenance of lung tissue health. Mutations in this gene can disrupt its function, leading to or exacerbating the development of pulmonary fibrosis.
This genetic test is particularly valuable for individuals with a family history of IPF or those exhibiting symptoms of the disease, as it can provide crucial information for early diagnosis and management. Early detection of a predisposition to IPF can lead to more effective monitoring and timely interventions, potentially improving the quality of life and outcomes for affected individuals.
The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the test is set at 4400 AED, reflecting the specialized nature of the testing and the expertise required to accurately interpret the results. Individuals considering this test should consult with healthcare professionals to understand its implications fully and to integrate its findings effectively into their health management plans.
The "CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test" is a specialized diagnostic examination offered at DNA Labs UAE, designed to identify mutations in the CACNA1D gene. These mutations are known to be associated with a rare condition that affects both the heart and hearing, leading to sinoatrial node dysfunction and deafness. The sinoatrial node is crucial for heart rhythm regulation, and its dysfunction can lead to arrhythmias and other cardiac issues. Concurrently, mutations in the CACNA1D gene can also impact auditory function, leading to various degrees of hearing loss.
This genetic test is crucial for individuals who exhibit symptoms of either condition or have a family history of sinoatrial node dysfunction or deafness, as it can provide definitive genetic evidence of the mutation. Early detection through this test allows for timely management and treatment of the conditions, potentially improving the quality of life and health outcomes for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze genetic information accurately. Results from this test can guide healthcare professionals in creating a personalized treatment plan for patients, taking into account their specific genetic makeup and the potential risks associated with these genetic mutations.
The MITF Gene Tietz Albinism-Deafness Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the MITF gene, which are responsible for Tietz Syndrome. This rare genetic disorder is characterized by albinism, resulting in very light skin and hair, severe hearing loss, and vision problems. The test is crucial for early diagnosis and management of the syndrome, enabling healthcare providers to offer appropriate treatments and interventions.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to detect any abnormalities in the MITF gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately diagnose this condition. Given the rarity of Tietz Syndrome and the importance of early detection for effective management, this genetic test is an invaluable tool for affected individuals and their families.
The WFS1 Gene Wolfram Syndrome Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the WFS1 gene, which are indicative of Wolfram Syndrome Type 1. This rare, genetic disorder is characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, collectively known as DIDMOAD. The test is crucial for individuals showing symptoms of the syndrome or those with a family history of the condition, as it provides essential information for diagnosis, management, and genetic counseling. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect the specific gene mutations associated with this condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with Wolfram Syndrome Type 1.
The CISD2 Gene Wolfram Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the CISD2 gene that are associated with Wolfram Syndrome Type 2. This rare genetic disorder is characterized by diabetes mellitus, optic atrophy, and deafness, among other symptoms. Early and accurate detection through this test can aid in the management and treatment of the condition. The test is priced at 4400 AED and involves analyzing the patient's DNA to identify any genetic variations that may indicate the presence of the syndrome. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is crucial for individuals with a family history of Wolfram Syndrome Type 2 or those exhibiting symptoms related to the disorder, providing them with valuable insights into their genetic health.
